T2 Biosystems (TTOO) Short Interest Ratio & Short Volume $0.41 +0.07 (+18.84%) (As of 12/26/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends T2 Biosystems Short Interest DataT2 Biosystems (TTOO) has a short interest of 624,900 shares, representing 6.69% of the float (the number of shares available for trading by the public). This marks a -28.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 403,060 shares to cover all short positions.Current Short Interest624,900 sharesPrevious Short Interest875,200 sharesChange Vs. Previous Month-28.60%Dollar Volume Sold Short$228,088.50Short Interest Ratio0.8 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares21,043,000 sharesFloat Size9,340,000 sharesShort Percent of Float6.69%Today's Trading Volume1,730,524 sharesAverage Trading Volume403,060 sharesToday's Volume Vs. Average429% Short Selling T2 Biosystems? Sign up to receive the latest short interest report for T2 Biosystems and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTTOO Short Interest Over TimeTTOO Days to Cover Over TimeTTOO Percentage of Float Shorted Over Time Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. T2 Biosystems Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024624,900 shares $228,088.50 -28.6%6.7%0.8 $0.37 11/30/2024875,200 shares $500,876.96 -14.2%12.6%1.3 $0.57 11/15/20241,020,000 shares $506,940.00 +22.2%14.7%1.8 $0.50 10/31/2024834,800 shares $731,201.32 +47.4%14.4%1.9 $0.88 10/15/2024566,500 shares $815,760.00 +59.4%9.4%1.8 $1.44 9/30/2024355,300 shares $699,941.00 -5.1%5.9%1.8 $1.97 Get the Latest News and Ratings for TTOO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024374,300 shares $946,979.00 +17.6%6.2%2.2 $2.53 8/31/2024318,400 shares $1.02 million +1.6%5.3%2 $3.19 8/15/2024313,300 shares $1.11 million -26.6%5.3%2 $3.56 7/31/2024426,800 shares $2.08 million +11.5%8.7%1.9 $4.88 7/15/2024382,700 shares $2.14 million -8.3%8.9%1.3 $5.60 6/30/2024417,100 shares $2.23 million +32.0%7.7%1.3 $5.34 6/15/2024316,000 shares $1.61 million +8.7%5.8%1 $5.11 5/31/2024290,800 shares $1.49 million -54.3%10.3%0.9 $5.14 5/15/2024636,500 shares $3.80 million +7.4%22.5%1.9 $5.97 4/30/2024592,500 shares $1.99 million +58.2%N/A1.8 $3.36 4/15/2024374,500 shares $1.11 million -5.6%N/A1.3 $2.97 3/31/2024396,900 shares $1.19 million +34.4%11.6%1.6 $3.00 3/15/2024295,400 shares $1.23 million -6.6%9.7%0.9 $4.18 2/29/2024316,400 shares $1.59 million -25.4%9.9%0.9 $5.04 2/15/2024424,000 shares $2.71 million +31.3%13.3%1.2 $6.39 1/31/2024323,000 shares $1.45 million -2.1%8.0%1.1 $4.50 1/15/2024329,800 shares $1.37 million +18.6%8.2%0.8 $4.16 12/31/2023278,000 shares $1.74 million +16.3%6.9%0.5 $6.28 12/15/2023239,100 shares $899,016.00 -16.3%6.0%0.4 $3.76 11/30/2023285,600 shares $1.01 million -9.2%7.1%0.4 $3.54 11/15/2023314,500 shares $1.36 million -8.6%7.8%0.4 $4.33 10/31/2023344,000 shares $2.03 million -45.7%10.4%0.4 $5.91 10/15/2023633,500 shares $5.19 million -97.5%19.2%0.5 $8.20 9/30/202325,370,000 shares $5.60 million +7.0%N/A0.2 $0.22 9/15/202323,710,000 shares $6.57 million -3.3%N/A0.2 $0.28 8/31/202324,510,000 shares $7.67 million -8.8%N/A0.2 $0.31 8/15/202326,870,000 shares $15.88 million +72.4%N/A0.2 $0.59 7/31/202315,590,000 shares $2.30 million +716.2%N/A0.2 $0.15 7/15/20231,910,000 shares $212,583.00 +34.5%N/A0 $0.11 6/30/20231,420,000 shares $100,252.00 -41.3%6.6%0 $0.07 6/15/20232,420,000 shares $215,380.00 +869.9%11.2%0.1 $0.09 5/31/2023249,500 shares $22,455.00 -47.7%1.1%0 $0.09 5/15/2023476,900 shares $131,099.81 -4.9%2.0%0.6 $0.27 4/30/2023501,500 shares $165,495.00 +15.8%2.6%0.7 $0.33Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 4/15/2023433,200 shares $172,413.60 -24.1%2.6%0.6 $0.40 3/31/2023570,500 shares $262,430.00 +8.8%3.4%0.9 $0.46 3/15/2023524,300 shares $277,144.98 -51.5%8.6%0.8 $0.53 2/28/20231,080,000 shares $664,200.00 +6.9%17.6%2.3 $0.62 2/15/20231,010,000 shares $837,896.00 +99.4%16.5%2.3 $0.83 1/31/2023506,600 shares $795,362.00 -7.7%7.1%2.9 $1.57 1/15/2023548,700 shares $1.12 million -15.7%7.6%3 $2.04 12/30/2022650,600 shares $923,852.00 +6.7%9.0%2.1 $1.42 12/15/2022609,800 shares $823,230.00 -2.2%8.4%2.1 $1.35 11/30/2022623,200 shares $1.03 million -6.1%8.6%1.8 $1.66 11/15/2022664,000 shares $1.35 million +41.0%9.1%1.6 $2.03 10/31/2022470,900 shares $871,165.00 -22.4%6.7%0.6 $1.85 10/15/2022607,000 shares $1.41 million -96.2%8.7%0.6 $2.32 9/30/202215,790,000 shares $1.78 million +0.9%N/A0.4 $0.11 9/15/202215,650,000 shares $1.82 million +5.9%N/A0.4 $0.12 8/31/202214,780,000 shares $1.81 million -31.1%N/A0.4 $0.12 8/15/202221,440,000 shares $4.40 million +36.5%N/A0.6 $0.21 7/31/202215,710,000 shares $1.89 million +8.3%N/A1.1 $0.12 7/15/202214,500,000 shares $2.02 million +61.7%N/A2.1 $0.14 6/30/20228,970,000 shares $1.45 million -8.1%N/A1.9 $0.16 6/15/20229,760,000 shares $1.66 million +6.4%N/A4.9 $0.17 5/31/20229,170,000 shares $1.85 million -3.0%N/A6.6 $0.20 5/15/20229,450,000 shares $2.15 million +9.5%N/A7.1 $0.23 4/30/20228,630,000 shares $3.19 million +9.2%N/A6.8 $0.37 4/15/20227,900,000 shares $3.87 million -2.7%N/A6.4 $0.49 3/31/20228,120,000 shares $4.26 million +7.8%N/A5.9 $0.52 3/15/20227,530,000 shares $2.77 million +5.2%N/A4.8 $0.37 2/28/20227,160,000 shares $3.12 million +27.2%N/A4.3 $0.44 2/15/20225,630,000 shares $2.65 million -4.9%N/A2.9 $0.47 1/31/20225,920,000 shares $2.49 million -22.7%N/A2.9 $0.42 1/15/20227,660,000 shares $3.19 million +18.0%N/A3.4 $0.42 12/31/20216,490,000 shares $3.35 million -5.5%N/A2.6 $0.52 12/15/20216,870,000 shares $3.68 million -21.5%N/A2.8 $0.54 11/30/20218,750,000 shares $5.43 million +1.2%N/A2.5 $0.62 11/15/20218,650,000 shares $6.14 million +8.7%N/A2.7 $0.71 10/29/20217,960,000 shares $6.17 million +7.7%N/A2.4 $0.78 10/15/20217,390,000 shares $6.11 million -0.1%N/A2.1 $0.83 9/30/20217,400,000 shares $6.77 million -14.7%N/A2.1 $0.92 9/15/20218,670,000 shares $9.02 million +26.9%N/A2.4 $1.04 8/31/20216,830,000 shares $6.38 million -25.1%N/A1.9 $0.93 8/13/20219,120,000 shares $9.30 million -2.5%N/A2.1 $1.02 7/30/20219,350,000 shares $9.63 million +13.2%6.6%2.2 $1.03 7/15/20218,260,000 shares $8.67 million +8.0%5.8%1.9 $1.05 6/30/20217,650,000 shares $9.10 million -4.1%5.4%1.8 $1.19 6/15/20217,980,000 shares $10.29 million -19.2%5.6%1.8 $1.29 5/28/20219,880,000 shares $13.73 million -7.6%6.9%2.1 $1.39 5/14/202110,690,000 shares $11.12 million -9.8%N/A2.3 $1.04 4/30/202111,850,000 shares $16.71 million +7.1%N/A1.9 $1.41 4/15/202111,070,000 shares $15.72 million +1.5%N/A1.1 $1.42 3/31/202110,910,000 shares $16.86 million +6.5%N/A0.9 $1.55Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/15/202110,240,000 shares $20.79 million +8.7%N/A0.8 $2.03 2/26/20219,420,000 shares $21.95 million -3.5%N/A0.8 $2.33 2/12/20219,760,000 shares $31.04 million +7.0%N/A0.8 $3.18 1/29/20219,120,000 shares $18.42 million -6.3%N/A0.8 $2.02 1/15/20219,730,000 shares $17.32 million +26.7%N/A1.3 $1.78 12/31/20207,680,000 shares $9.60 million -4.8%N/A1.5 $1.25 12/15/20208,070,000 shares $8.96 million -16.0%N/A2.6 $1.11 11/30/20209,610,000 shares $10.86 million -9.1%N/A3 $1.13 11/15/202010,570,000 shares $12.79 million -5.1%N/A2.3 $1.21 10/30/202011,140,000 shares $14.82 million -16.9%N/A2.2 $1.33 10/15/202013,400,000 shares $17.82 million -2.5%N/A2 $1.33 9/30/202013,740,000 shares $18.69 million +9.5%N/A1.6 $1.36 9/15/202012,550,000 shares $16.06 million +14.6%N/A1 $1.28 8/31/202010,950,000 shares $17.08 million -1.2%N/A0.8 $1.56 8/14/202011,080,000 shares $16.40 million +4.4%N/A0.8 $1.48 7/31/202010,610,000 shares $17.61 million -6.2%N/A0.7 $1.66 7/15/202011,310,000 shares $17.87 million +62.7%N/A0.8 $1.58 6/30/20206,950,000 shares $8.83 million +7.9%N/A0.5 $1.27 6/15/20206,440,000 shares $10.50 million -7.9%N/A0.5 $1.63 5/29/20206,990,000 shares $5.87 million +15.4%N/A0.5 $0.84 5/15/20206,060,000 shares $3.39 million +28.4%N/A0.4 $0.56 4/30/20204,720,000 shares $2.57 million -15.6%N/A0.4 $0.55 4/15/20205,590,000 shares $3.05 million -33.3%N/A0.5 $0.55 3/31/20208,380,000 shares $4.44 million +73.8%N/A0.9 $0.53 3/13/20204,822,000 shares $2.36 million -14.8%13.7%0.3 $0.49 2/28/20205,660,000 shares $2.26 million +23.3%16.1%2.2 $0.40 2/14/20204,590,000 shares $2.30 million +14.2%11.6%5.8 $0.50 1/31/20204,020,000 shares $2.53 million -2.4%10.2%5.5 $0.63 1/15/20204,120,000 shares $3.38 million +16.4%10.5%6.6 $0.82 12/31/20193,540,000 shares $4.14 million -17.3%9.0%6 $1.17 TTOO Short Interest - Frequently Asked Questions What is T2 Biosystems' current short interest? Short interest is the volume of T2 Biosystems shares that have been sold short but have not yet been closed out or covered. As of December 15th, traders have sold 624,900 shares of TTOO short. 6.69% of T2 Biosystems' shares are currently sold short. Learn More on T2 Biosystems' current short interest. What is a good short interest ratio for T2 Biosystems? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TTOO shares currently have a short interest ratio of 1.0. Learn More on T2 Biosystems's short interest ratio. What is a good short interest percentage for T2 Biosystems? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.69% of T2 Biosystems' floating shares are currently sold short. Is T2 Biosystems' short interest increasing or decreasing? T2 Biosystems saw a decrease in short interest in the month of December. As of December 15th, there was short interest totaling 624,900 shares, a decrease of 28.6% from the previous total of 875,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is T2 Biosystems' float size? T2 Biosystems currently has issued a total of 21,043,000 shares. Some of T2 Biosystems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. T2 Biosystems currently has a public float of 9,340,000 shares. How does T2 Biosystems' short interest compare to its competitors? 6.69% of T2 Biosystems' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to T2 Biosystems: IRIDEX Co. (2.44%), DarioHealth Corp. (5.90%), Vivos Therapeutics, Inc. (3.85%), Femasys Inc. (2.04%), Co-Diagnostics, Inc. (0.73%), Allurion Technologies Inc. (2.25%), PolyPid Ltd. (0.47%), Microbot Medical Inc. (3.41%), Nephros, Inc. (0.05%), Inspira Technologies Oxy B.H.N. Ltd. (1.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short T2 Biosystems stock? Short selling TTOO is an investing strategy that aims to generate trading profit from T2 Biosystems as its price is falling. TTOO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against T2 Biosystems? A short squeeze for T2 Biosystems occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TTOO, which in turn drives the price of the stock up even further. How often is T2 Biosystems' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TTOO, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies IRIDEX Short Interest Data DarioHealth Short Interest Data Vivos Therapeutics Short Interest Data Femasys Short Interest Data Co-Diagnostics Short Interest Data Allurion Technologies Short Interest Data PolyPid Short Interest Data Microbot Medical Short Interest Data Nephros Short Interest Data Inspira Technologies Oxy B.H.N. Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TTOO) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
